Are personalised treatments of adult depression finally within reach?
作者信息
Cuijpers P, Christensen H
机构信息
Department of Clinical, Neuro and Developmental Psychology,Vrije Universiteit Amsterdam,The Netherlands.
Black Dog Institute, University of New South Wales,Randwick, NSW,Australia.
出版信息
Epidemiol Psychiatr Sci. 2017 Feb;26(1):40-42. doi: 10.1017/S204579601600007X. Epub 2016 Mar 11.
Abstract
摘要
相似文献
1
Are personalised treatments of adult depression finally within reach?成人抑郁症的个性化治疗终于触手可及了吗？
Epidemiol Psychiatr Sci. 2017 Feb;26(1):40-42. doi: 10.1017/S204579601600007X. Epub 2016 Mar 11.
2
Targeting treatments for depression: what can our patients tell us?抑郁症的靶向治疗：我们的患者能告诉我们什么？
Epidemiol Psychiatr Sci. 2017 Feb;26(1):37-39. doi: 10.1017/S2045796016000160. Epub 2016 Apr 5.
3
Personalized medicine for depression: can we match patients with treatments?抑郁的个体化医学：我们能否将患者与治疗方法相匹配？
Am J Psychiatry. 2010 Dec;167(12):1445-55. doi: 10.1176/appi.ajp.2010.09111680. Epub 2010 Sep 15.
4
Symptom-Specific Effects of Psychotherapy versus Combined Therapy in the Treatment of Mild to Moderate Depression: A Network Approach.心理治疗与联合治疗对轻至中度抑郁症的症状特异性影响：一种网状分析方法
Psychother Psychosom. 2018;87(2):121-123. doi: 10.1159/000486793. Epub 2018 Mar 1.
5
6
Adolescent Depression-Pharmacotherapy or Psychotherapy?青少年抑郁症——药物治疗还是心理治疗？
J Dev Behav Pediatr. 2016 Apr;37(3):264. doi: 10.1097/DBP.0000000000000264.
7
[Psychological treatment of depression].[抑郁症的心理治疗]
Ugeskr Laeger. 2007 Apr 16;169(16):1444-7.
8
Psychopharmacology plus psychotherapy for depression treatment.精神药理学加心理治疗用于抑郁症治疗。
Psychiatr Serv. 2003 Jul;54(7):1042; author reply 1042-3. doi: 10.1176/appi.ps.54.7.1042-a.
9
[The Multidisciplinary Guideline for Depression: a commentary].[《抑郁症多学科指南：一篇评论》]
Tijdschr Psychiatr. 2006;48(12):921-5.
10
What are the chances for personalised treatment with antidepressants? Detection of patient-by-treatment interaction with a variance ratio meta-analysis.使用抗抑郁药进行个性化治疗的可能性有多大？通过方差比荟萃分析检测患者与治疗的相互作用。
BMJ Open. 2019 Dec 23;9(12):e034816. doi: 10.1136/bmjopen-2019-034816.
引用本文的文献
1
Personalised & optimised therapy (POT) algorithm using five cognitive and behavioural skills for subthreshold depression.使用五种认知和行为技能治疗亚阈值抑郁症的个性化与优化治疗（POT）算法
NPJ Digit Med. 2025 Aug 20;8(1):531. doi: 10.1038/s41746-025-01906-6.
2
Nature-Based Meditation, Rumination and Mental Wellbeing.基于自然的冥想、沉思与心理健康。
Int J Environ Res Public Health. 2022 Jul 26;19(15):9118. doi: 10.3390/ijerph19159118.
3
The Potential for Outdoor Nature-Based Interventions in the Treatment and Prevention of Depression.基于户外自然干预在抑郁症治疗与预防中的潜力
Front Psychol. 2022 Mar 23;13:740210. doi: 10.3389/fpsyg.2022.740210. eCollection 2022.
4
Moving beyond a 'one-size-fits-all' rationale in global mental health: prospects of a precision psychology paradigm.超越全球心理健康领域的“一刀切”理念：精准心理学范式的前景。
Epidemiol Psychiatr Sci. 2021 Oct 11;30:e63. doi: 10.1017/S2045796021000500.
5
Moderators of intervention efficacy for Finding My Way: A web-based psychosocial intervention for cancer-related distress.《寻找我的路》干预效果的调节因素：一种基于网络的癌症相关困扰的心理社会干预。
Support Care Cancer. 2021 Dec;29(12):7669-7678. doi: 10.1007/s00520-021-06291-w. Epub 2021 Jun 17.
6
The D*Phase-study: study protocol for a pragmatic two-phased, randomised controlled (non-inferiority) trial that addresses treatment non-response and compares cognitive behavioural therapy and short-term psychodynamic supportive psychotherapy for major depression.D*Phase 研究：一项实用两阶段、随机对照（非劣效性）试验的研究方案，旨在解决治疗无反应问题，并比较认知行为疗法和短期心理动力学支持性心理疗法治疗重度抑郁症的疗效。
BMC Psychiatry. 2021 May 4;21(1):233. doi: 10.1186/s12888-021-03156-8.
7
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.抗抑郁药反应的个体差异：安慰剂对照随机临床试验的荟萃分析。
JAMA Psychiatry. 2021 May 1;78(5):490-497. doi: 10.1001/jamapsychiatry.2020.4564.
8
Redefining Therapeutic Outcomes of Depression Treatment.重新定义抑郁症治疗的疗效
J Pers Oriented Res. 2019 Dec 30;5(2):1-8. doi: 10.17505/jpor.2019.10. eCollection 2019.
9
Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials.抗抑郁药反应的个体差异：安慰剂对照随机临床试验的荟萃分析
JAMA Psychiatry. 2020 Jun 1;77(6):607-617. doi: 10.1001/jamapsychiatry.2019.4815.
10
Personalising psychotherapies for depression using a novel mixed methods approach: an example from Morita therapy.使用新型混合方法对抑郁症进行个体化心理治疗：来自森田疗法的实例。
Trials. 2020 Jan 8;21(1):41. doi: 10.1186/s13063-019-3788-3.
本文引用的文献
1
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.利用患者自我报告研究重度抑郁症治疗效果的异质性。
Epidemiol Psychiatr Sci. 2017 Feb;26(1):22-36. doi: 10.1017/S2045796016000020. Epub 2016 Jan 26.
2
The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration.个性化优势指数：将预测研究转化为个性化治疗建议。一项示范。
PLoS One. 2014 Jan 8;9(1):e83875. doi: 10.1371/journal.pone.0083875. eCollection 2014.
3
Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.发现、比较和综合随机临床试验后治疗结果的调节因素：一种参数方法。
Stat Med. 2013 May 20;32(11):1964-73. doi: 10.1002/sim.5734. Epub 2013 Jan 10.
4
Data-driven subtypes of major depressive disorder: a systematic review.基于数据驱动的重性抑郁障碍亚型：系统综述。
BMC Med. 2012 Dec 4;10:156. doi: 10.1186/1741-7015-10-156.
5
Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review.成人抑郁症的个体化治疗：药物治疗、心理治疗还是两者结合？系统评价。
Depress Anxiety. 2012 Oct;29(10):855-64. doi: 10.1002/da.21985. Epub 2012 Jul 19.
6
Meta-review of depressive subtyping models.抑郁亚型模型的元综述。
J Affect Disord. 2012 Jul;139(2):126-40. doi: 10.1016/j.jad.2011.07.015. Epub 2011 Sep 1.
7
How can we realize the promise of personalized antidepressant medicines?我们如何才能实现个性化抗抑郁药物的前景？
Nat Rev Neurosci. 2008 Aug;9(8):638-46. doi: 10.1038/nrn2453. Epub 2008 Jul 16.
8
Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders.利用调查数据为公共政策提供信息：十种精神障碍治疗的成本效益比较。
Br J Psychiatry. 2004 Jun;184:526-33. doi: 10.1192/bjp.184.6.526.
Zotero 插件